Related Stories
![logo](https://udic.es/wp-content/uploads/2017/07/logo.png)
![logo](https://udic.es/wp-content/uploads/2017/07/logo.png)
![logo](https://udic.es/wp-content/uploads/2017/07/logo.png)
21 de November de 2023
Trial on LRRK2 mutation in Parkinson’s disease is about to be completed. Our Clinical Trials…
Posted in: Uncategorised
![logo](https://udic.es/wp-content/uploads/2017/07/logo.png)
8 de May de 2023
Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…
Posted in: Parkinson
![logo](https://udic.es/wp-content/uploads/2017/07/logo.png)
8 de May de 2023
The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…
Posted in: Parkinson
![Area privada5](https://udic.es/wp-content/uploads/2017/11/Area-privada5-262x201.jpg)
16 de January de 2023
On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…
![Area privada1](https://udic.es/wp-content/uploads/2017/11/Area-privada1-262x201.jpg)
3 de June de 2021
The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…
Posted in: Alzeimer, Uncategorised
![Blogudic1](https://udic.es/wp-content/uploads/2019/03/Blogudic1-262x201.jpg)